In this Book

University of California Press
summary
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation.Pills, Power, and Policyoffers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic researchers, the book provides essential historical context for understanding how corporate interests came to dominate American health care policy after World War II.

Table of Contents

  1. Cover
  2. pp. 1-1
  3. restricted access Download |
  1. Title Page. Series Page, Copyright, Dedication
  2. pp. i-viii
  3. restricted access Download |
  1. Contents
  2. pp. ix-x
  3. restricted access Download |
  1. Foreword
  2. pp. xi-xii
  3. restricted access Download |
  1. Acknowledgments
  2. pp. xiii-xvi
  3. restricted access Download |
  1. Introduction: Pharmaceutical Politics, Then and Now
  2. pp. 1-10
  3. restricted access Download |
  1. PART I: FORGING PHARMACEUTICAL RELATIONS
  2. pp. 11-12
  1. 1. Knowledgeable Relations: The Building of a Pharmaceutical Research Network
  2. pp. 13-36
  3. restricted access Download |
  1. 2. Workforce Relations: The Invention of the Pharmaceutical Postdoctoral Fellowship
  2. pp. 37-58
  3. restricted access Download |
  1. 3. Professional Relations: Crafting the Public Image of the Health Care Team
  2. pp. 59-86
  3. restricted access Download |
  1. PART II: ALLIED AGAINST REFORM
  2. pp. 87-88
  1. 4. Cold War Alliances: Kefauver’s Bid for Pharmaceutical Reform
  2. pp. 89-120
  3. restricted access Download |
  1. 5. Expert Alliances: The Creation of the Drug Research Board
  2. pp. 121-162
  3. restricted access Download |
  1. 6. Generic Alliances and the Backlash against Regulatory Reform
  2. pp. 163-192
  3. restricted access Download |
  1. Epilogue
  2. pp. 193-208
  3. restricted access Download |
  1. Notes
  2. pp. 209-266
  3. restricted access Download |
  1. Bibliography
  2. pp. 267-282
  3. restricted access Download |
  1. Index
  2. pp. 283-294
  3. restricted access Download |
Back To Top

This website uses cookies to ensure you get the best experience on our website. Without cookies your experience may not be seamless.